Clinical trial
The Role of Ischemia Modified Albumin in Patients With COVID-19
NCT05286268 is registered in ClinicalTrials.gov with Larissa University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Ischemia Modified Albumin in Patients With COVID-19
- Lead sponsor
- Larissa University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 6, 2022
- Completion date
- July 31, 2022
- Enrollment
- 194 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.